By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – French biopharmaceutical firm Transgene today and the Ligue nationale contre le cancer, or the French league against cancer, today announced an agreement to identify membrane-specific targets from gene expression data in order to develop new oncology biotherapies.

The data was collected by Ligue from more than 4,800 tumors.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.